Saumya Pandey
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: saumya pandey | Updated : December 12, 2023 8:01 AM IST
Image credits by: Challenging traditional notions and opening new possibilities for probiotic intervention.
The food industry's longstanding reliance on fungal strains for fermentation and flavor production takes a new turn as a study unveils potential probiotic effects. This research published in the journal of the American Society for Microbiology, delves into the largely unexplored realm of foodborne yeasts and sheds light on their impact on gut microbiota and potential benefits for gut health. Historically, certain fungi like Saccharomyces cerevisiae played crucial roles in wine and bread production, while others like Debaryomyces hansenii contributed to cheese production. The study's focus was to unravel the impact of fungi used in food processes on human gut health, particularly their role in the development of Inflammatory Bowel Diseases (IBD), such as Crohn's disease and ulcerative colitis.
The researchers strategically selected yeasts extensively employed in food production, representing a diverse range of species. Through interaction tests with human cells and an animal model simulating ulcerative colitis, they identified potential probiotic effects in the strains. Two yeasts, Cyberlindnera jadinii, and Kluyveromyces lactis, stood out for their beneficial impact on gut inflammation in a mouse model of ulcerative colitis.
Intriguingly, the study delved into the mechanisms behind these probiotic effects. For Cyberlindnera jadinii, the protection against gut inflammation seemed linked to modifications in the bacterial microbiota after administering the yeast to mice. The precise mechanism driving this modification and its subsequent impact on inflammation remain unknown but present a promising avenue for further exploration.
The strains Cyberlindnera jadinii and Kluyveromyces lactis, despite not being previously associated with such beneficial effects, emerge as potential probiotic yeast candidates to combat gut inflammation. While the discovery holds promise, further studies are imperative to unravel the intricacies of their efficiency, particularly in human contexts.
The study's findings not only underscore the potential probiotic role of specific foodborne yeasts but also illuminate a promising discovery in the realm of gut health. As research in this domain progresses, understanding the mechanisms by which these yeasts exert their effects could pave the way for novel interventions in tackling inflammatory conditions in the gut.
In conclusion, the exploration of foodborne yeasts unveils a potential symbiotic relationship between these fungi and gut health, challenging traditional notions and opening new possibilities for probiotic interventions in the ever-evolving landscape of microbiota research.
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.